The levels of p-Smad2, p-Smad3, and Smad4 were significantly increased (P < 0.01) and the levels of Smad7 were dramatically decreased (P < 0.05) in the PCOS group as compared to the control group (Figure 8). This evidence concerns the gene SMAD2 and polycystic ovary syndrome.